Approximately 5% of patients presenting with breast cancer had a PV in one of the high penetrance genes, (BRCA1, BRCA2, TP53, PALB2, CDH1, and PTEN), and an additional 7.5% patients had a PV in one of the moderate penetrance genes (Table 2). The gene discussed is BRCA1; the disease is breast carcinoma.